These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10204359)

  • 1. [An amino acid metabolic complex in optimizing the cardiac hemodynamic characteristics of patients with ischemic heart disease].
    Berezin AE; Fushteĭ IM; Kraĭdashenko OV
    Lik Sprava; 1998 Dec; (8):94-6. PubMed ID: 10204359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The optimization of the hemodynamic characteristics in patients with ischemic heart disease and circulatory failure by using a substrate-coenzyme complex].
    Vizir AD; Dunaev VV; Berezin AE; Kraĭdashenko OV
    Lik Sprava; 1997; (5):53-6. PubMed ID: 9491697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative efficacy of combined therapy with preductal and amino acid composition in elderly patients with coronary heart disease and class II-III angina].
    Zaslavskaia RM; Kelimberdieva ES; Komissarova IA; Teĭblium MM; Goncharov LF; Goncharova ZF; Akhmetov KZh
    Ter Arkh; 1999; 71(11):58-61. PubMed ID: 10626340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of antianginal preparations on the hemodynamics and metabolism of the ischemic myocardium].
    Makolkin VI; Vakhliaev VD
    Eksp Klin Farmakol; 1996; 59(4):18-20. PubMed ID: 9026181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Agents for the metabolic correction of myocardial energy metabolism in treating patients with ischemic heart disease].
    Vizyr AD; Kraĭdashenko OV; Berezin OIe; Oliĭnyk OI
    Lik Sprava; 2000 Mar; (2):26-30. PubMed ID: 10862469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of the new cardioprotective agent thiotriazoline in the therapy of ischemic heart disease in older patients].
    Dunaev VV; Kraĭdashenko OV; Berezin AE
    Eksp Klin Farmakol; 1996; 59(1):21-3. PubMed ID: 8704625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The potentials of combined anti-arrhythmia therapy with the use of neuroactive amino acids in patients with ischemic heart disease].
    Skibitskiĭ VV
    Ter Arkh; 1992; 64(8):25-9. PubMed ID: 1279829
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of helium-neon laser irradiation on myocardial and thyroid functions in patients with ischemic heart disease].
    Ruzov VI; Rubanova MP; Grigor'ev MIu; Cherkunov KV
    Vopr Kurortol Fizioter Lech Fiz Kult; 1997; (5):7-9. PubMed ID: 9446315
    [No Abstract]   [Full Text] [Related]  

  • 9. [A mathematical analysis of the cardiac activity indices in patients with ischemic heart disease undergoing antianginal pharmacotherapy].
    Arushanian EB; Shamliian TA
    Eksp Klin Farmakol; 1995; 58(1):31-3. PubMed ID: 7787692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A method for optimizing the finoptin treatment of patients with ischemic heart disease].
    Synchuk AN; Chursina TIa; Rozgon GI; Troian NF; Kiriliuk NA; Glibka AZ
    Lik Sprava; 1995; (3-4):140-2. PubMed ID: 8819947
    [No Abstract]   [Full Text] [Related]  

  • 11. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
    Belardinelli R
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The preoperative drug correction of disorders in myocardial functional reserve in patients with ischemic heart disease].
    Molodan AV; Salgalov AV; Osaulenko VV; Materukhin AN
    Klin Khir (1962); 1994; (5):29-31. PubMed ID: 7807893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A clinico-pharmacological study of the antianginal and anti-ischemic efficacy of a new drug form of diltiazem with delayed release].
    Belousov IuB; Upnitskiĭ AA; Sokolov AV; Tishchenkova NF; Karasev AV; Egorova NA
    Ter Arkh; 1997; 69(3):61-3. PubMed ID: 9229836
    [No Abstract]   [Full Text] [Related]  

  • 14. [The possibilities for the pathogenetic therapy of ischemic heart disease under cardioselective loading].
    Ardashev VN; Smirnov AV; Ryndin AA; Shcherbak IuA
    Voen Med Zh; 1994 Jul; (7):29-31, 79. PubMed ID: 7810109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperbaric oxygenation and antianginal preparations: the effect of a single combined use on the functional indices of the state of the heart in patients with angina pectoris].
    Seriakov VV; Efuni SN; Sidorenko BA
    Anesteziol Reanimatol; 1992; (2):9-13. PubMed ID: 1416216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical efficacy of the calcium antagonist amlodipine in patients with ischemic heart disease and arterial hypertension].
    Zviagina TV
    Lik Sprava; 2000; (5):114-7. PubMed ID: 11031470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of the antioxidant coenzyme Q10 as a cytoprotection variant in ischemic heart disease].
    Syrkin AL; Kogan AKh; Drinitsina SV; Kuznetsov AB; Pechorina EA; Frenkel' EE; Kuleshova NN; Golovnia LD
    Klin Med (Mosk); 1998; 76(7):24-8. PubMed ID: 9742773
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dynamics of immunologic indices in patients with ischemic heart disease on a course of doxazosin therapy].
    Lyzohub VH; Savchenko OV; Chumak AA; Dykukha IS
    Lik Sprava; 2003; (5-6):85-9. PubMed ID: 14618814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of alpha-1 adrenergic blockade on the clinical course, immune status and blood plasma lipid spectrum in patients with ischemic heart disease].
    Lizogub VG; Chumak AA; Savchenko AV; Pliskevich DA
    Lik Sprava; 2000; (3-4):31-4. PubMed ID: 10921255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinico-hemodynamic effects of the antioxidant ceruloplasmin in IHD patients].
    Zakirova AN
    Ter Arkh; 1995; 67(4):33-5. PubMed ID: 7784970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.